Updated
Updated · Military Times · Aug 18
VA Details 34-Step PTSD Guideline Path for Mental Health Treatments
Updated
Updated · Military Times · Aug 18

VA Details 34-Step PTSD Guideline Path for Mental Health Treatments

2 articles · Updated · Military Times · Aug 18

Summary

  • VA said mental health treatments do not become routine care after FDA approval alone; they move through research, clinical guidelines, formulary review, ethics and safety checks, and feasibility tests inside the department.
  • The 2023 VA/DoD PTSD guideline contains 34 evidence-based recommendations and uses a more rigorous GRADE review than the 2017 version, leading some recommendations to be downgraded as evidence was reassessed.
  • rTMS shows how that process works in practice: after FDA approval for depression in 2008, VA studied it in veterans, piloted it at 35 sites, and has since expanded access to more than 60 facilities.
  • VA said staffing, equipment, space and medication restrictions can still limit access, while the PTSD guideline recommends against benzodiazepines, cannabis products and maintains a weak recommendation against ketamine for PTSD.
  • Psychedelic-assisted therapies remain in research rather than routine care, and VA says monitoring continues even after rollout through adverse-event reporting, quality reviews and periodic guideline updates.

Insights

Why does FDA approval mean nothing for veterans seeking cutting-edge mental health treatments at the VA?
With standard PTSD therapy dropout rates exceeding 60 percent, is the VA strict approval process actually costing veterans their lives?